{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T15:15:00Z","timestamp":1717168500205},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2009,10,28]],"date-time":"2009-10-28T00:00:00Z","timestamp":1256688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00292-009-1215-3","type":"journal-article","created":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T17:23:07Z","timestamp":1256577787000},"page":"210-216","source":"Crossref","is-referenced-by-count":1,"title":["Ser\u00f6se Genitalkarzinome"],"prefix":"10.1007","volume":"30","author":[{"given":"S.","family":"Lax","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,28]]},"reference":[{"key":"1215_CR1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","volume":"442","author":"Al-Hussaini","year":"2004","unstructured":"Al-Hussaini M, Stockman A, Foster H, McCluggage WG (2004) WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology 442:109\u2013115","journal-title":"Histopathology"},{"key":"1215_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/gyno.2000.6066","volume":"802","author":"Alvarez","year":"2001","unstructured":"Alvarez AA, Moore WF, Robboy SJ et al (2001) K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary. Gynecol Oncol 802:201\u2013206","journal-title":"Gynecol Oncol"},{"key":"1215_CR3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/0046-8177(95)90203-1","volume":"2611","author":"Ambros","year":"1995","unstructured":"Ambros RA, Sherman ME, Zahn CM et al (1995) Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 2611:1260\u20131267","journal-title":"Hum Pathol"},{"key":"1215_CR4","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","volume":"737","author":"Bell","year":"1994","unstructured":"Bell DA, Scully RE (1994) Early de novo ovarian carcinoma. A study of fourteen cases. Cancer 737:1859\u20131864","journal-title":"Cancer"},{"key":"1215_CR5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","volume":"3010","author":"Carcangiu","year":"2006","unstructured":"Carcangiu ML, Peissel B, Pasini B et al (2006) Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature. Am J Surg Pathol 3010:1222\u20131230","journal-title":"Am J Surg Pathol"},{"key":"1215_CR6","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","volume":"2625","author":"Carlson","year":"2008","unstructured":"Carlson JW, Miron A, Jarboe EA et al (2008) Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 2625:4160\u20134165","journal-title":"J Clin Oncol"},{"key":"1215_CR7","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/humrep\/13.11.3114","volume":"1311","author":"Comer","year":"1998","unstructured":"Comer MT, Leese HJ, Southgate J (1998) Induction of a differentiated ciliated cell phenotype in primary cultures of Fallopian tube epithelium. Hum Reprod 1311:3114\u20133120","journal-title":"Hum Reprod"},{"key":"1215_CR8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","volume":"32","author":"Crum","year":"2009","unstructured":"Crum CP (2009) Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol 32:165\u2013170","journal-title":"Mol Oncol"},{"key":"1215_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","volume":"51","author":"Crum","year":"2007","unstructured":"Crum CP, Drapkin R, Kindelberger D et al (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 51:35\u201344","journal-title":"Clin Med Res"},{"key":"1215_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","volume":"191","author":"Crum","year":"2007","unstructured":"Crum CP, Drapkin R, Miron A et al (2007) The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 191:3\u20139","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1215_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1066896907306773","volume":"161","author":"Dotto","year":"2008","unstructured":"Dotto J, Tavassoli FA (2008) Serous intraepithelial carcinoma arising in an endometrial polyp: a proposal for modification of terminology. Int J Surg Pathol 161:8\u201310","journal-title":"Int J Surg Pathol"},{"key":"1215_CR12","unstructured":"Drapkin RL, Hecht JL (2006) Pathogenesis of ovarian cancer. In: Crum CP, Lee KR (eds) Diagnostic gynecologic and obstetric pathology. Elsevier Saunders, Philadelphia"},{"key":"1215_CR13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","volume":"1001","author":"Finch","year":"2006","unstructured":"Finch A, Shaw P, Rosen B et al (2006) Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol 1001:58\u201364","journal-title":"Gynecol Oncol"},{"key":"1215_CR14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","volume":"1133","author":"Folkins","year":"2009","unstructured":"Folkins AK, Jarboe EA, Roh MH, Crum CP (2009) Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol 1133:391\u2013396","journal-title":"Gynecol Oncol"},{"key":"1215_CR15","unstructured":"Hendrickson MR, Atkins KA, Kempson RL (2007) Uterus and Fallopian tubes. In: Mills SE (ed) Histology for pathologists, 3rd edn. Lippincott Williams & Wilkins, Philadelphia"},{"key":"1215_CR16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0b013e3181934390","volume":"284","author":"Jarboe","year":"2009","unstructured":"Jarboe EA, Miron A, Carlson JW et al (2009) Coexisting intraepithelial serous carcinomas of the endometrium and Fallopian tube: frequency and potential significance. Int J Gynecol Pathol 284:308\u2013315","journal-title":"Int J Gynecol Pathol"},{"key":"1215_CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/modpathol.2008.197","volume":"223","author":"Jarboe","year":"2009","unstructured":"Jarboe EA, Pizer ES, Miron A et al (2009) Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma. Mod Pathol 223:345\u2013350","journal-title":"Mod Pathol"},{"key":"1215_CR18","doi-asserted-by":"crossref","unstructured":"Jaubert F, Robboy SJ, Mutter GL, Fellous M (2009) Embryology. In: Robboy SJ, Mutter GS, Prat J et al (eds) Robboy\u2019s pathology of the female reproductive tract, 2nd edn. Churchill Livingstone Elsevier, London","DOI":"10.1016\/B978-0-443-07477-6.50006-8"},{"key":"1215_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","volume":"312","author":"Kindelberger","year":"2007","unstructured":"Kindelberger DW, Lee Y, Miron A et al (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 312:161\u2013169","journal-title":"Am J Surg Pathol"},{"key":"1215_CR20","first-page":"166","volume":"93","author":"Kupryjanczyk","year":"1996","unstructured":"Kupryjanczyk J, Thor AD, Beauchamp R et al (1996) Ovarian, peritoneal and endometrial serous carcinoma: clonal origin of multifocal disease. Mod Pathol 93:166\u2013173","journal-title":"Mod Pathol"},{"key":"1215_CR21","first-page":"151","volume":"272","author":"Kurman","year":"2008","unstructured":"Kurman RJ, Shih Ie M (2008) Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 272:151\u2013160","journal-title":"Int J Gynecol Pathol"},{"key":"1215_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","volume":"2111","author":"Lee","year":"2007","unstructured":"Lee Y, Miron A, Drapkin R et al (2007) A candidate precursor to serous carcinoma that originates in the distal Fallopian tube. J Pathol 2111:26\u201335","journal-title":"J Pathol"},{"key":"1215_CR23","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","volume":"2632","author":"Levanon","year":"2008","unstructured":"Levanon K, Crum C, Drapkin R (2008) New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 2632:5284\u20135293","journal-title":"J Clin Oncol"},{"key":"1215_CR24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","volume":"302","author":"Medeiros","year":"2006","unstructured":"Medeiros F, Muto MG, Lee Y et al (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 302:230\u2013236","journal-title":"Am J Surg Pathol"},{"key":"1215_CR25","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"34621","author":"Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 34621:1616\u20131622","journal-title":"N Engl J Med"},{"key":"1215_CR26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","volume":"333","author":"Roh","year":"2009","unstructured":"Roh MH, Kindelberger D, Crum CP (2009) Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am J Surg Pathol 333:376\u2013383","journal-title":"Am J Surg Pathol"},{"key":"1215_CR27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2008.07.018","volume":"1112","author":"Saleemuddin","year":"2008","unstructured":"Saleemuddin A, Folkins AK, Garrett L et al (2008) Risk factors for a serous cancer precursor (\u201ep53 signature\u201c) in women with inherited BRCA mutations. Gynecol Oncol 1112:226\u2013232","journal-title":"Gynecol Oncol"},{"key":"1215_CR28","doi-asserted-by":"crossref","unstructured":"Scully RE (1995) Early de novo ovarian cancer and cancer developing in benign ovarian lesions. Int J Gynaecol Obstet 49 [Suppl]:S9\u2013S15","DOI":"10.1016\/0020-7292(95)02404-Z"},{"key":"1215_CR29","unstructured":"Seidman JD, Russel P, Kurman RJ (2002) Surface epithelial tumors of the ovary. In: Kurman RJ (ed) Blaustein\u2019s pathology of the female genital tract, 5th edn. Springer, Berlin New York Heidelberg New York Tokio"},{"key":"1215_CR30","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0046-8177(95)90204-X","volume":"2611","author":"Sherman","year":"1995","unstructured":"Sherman ME, Bur ME, Kurman RJ (1995) p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 2611:1268\u20131274","journal-title":"Hum Pathol"},{"key":"1215_CR31","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"1645","author":"Shih","year":"2004","unstructured":"Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 1645:1511\u20131518","journal-title":"Am J Pathol"},{"key":"1215_CR32","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0002-9440(10)62549-7","volume":"1604","author":"Singer","year":"2002","unstructured":"Singer G, Kurman RJ, Chang HW et al (2002) Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol 1604:1223\u20131228","journal-title":"Am J Pathol"},{"key":"1215_CR33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","volume":"956","author":"Singer","year":"2003","unstructured":"Singer G, Oldt R 3rd, Cohen Y et al (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 956:484\u2013486","journal-title":"J Natl Cancer Inst"},{"key":"1215_CR34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004347-200301000-00009","volume":"221","author":"Singer","year":"2003","unstructured":"Singer G, Shih Ie M, Truskinovsky A et al (2003) Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor). Int J Gynecol Pathol 221:37\u201341","journal-title":"Int J Gynecol Pathol"},{"key":"1215_CR35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","volume":"292","author":"Singer","year":"2005","unstructured":"Singer G, Stohr R, Cope L et al (2005) Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Am J Surg Pathol 292:218\u2013224","journal-title":"Am J Surg Pathol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-009-1215-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-009-1215-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-009-1215-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:01:03Z","timestamp":1559041263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-009-1215-3"}},"subtitle":["Molekularpathogenese und Rolle des Fimbrientrichters"],"short-title":[],"issued":{"date-parts":[[2009,10,28]]},"references-count":35,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1007\/s00292-009-1215-3","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,28]]}}}